Mycobacterium tuberculosis remains a significant global pathogen, causing extensive morbidity and mortality worldwide. This bacterium persists within granulomatous lesions in a poorly characterized, nonreplicating state. The two-component signal transduction systems MprAB and DosRS-DosT (DevRS-Rv2027c) are responsive to conditions likely to be present within granulomatous lesions and mediate aspects of M. tuberculosis persistence in vitro and in vivo. Here, we describe a previously uncharacterized locus, Rv1813c-Rv1812c, that is coregulated by both MprA and DosR. We demonstrate that MprA and DosR bind to adjacent and overlapping sequences within the promoter region of Rv1813c and direct transcription from an initiation site located several hundred base pairs upstream of the Rv1813 translation start site. We further show that Rv1813c and Rv1812c are cotranscribed, and that the genomic organization of this operon is specific to M. tuberculosis and Mycobacterium bovis. Although Rv1813c is not required for survival of M. tuberculosis in vitro, including under conditions in which MprAB and DosRST signaling are activated, an M. tuberculosis ⌬Rv1813c mutant is attenuated in the low-dose aerosol model of murine tuberculosis, where it exhibits a lower bacterial burden, delayed time to death, and decreased ability to stimulate proinflammatory cytokines interleukin-1␤ (IL-1␤) and IL-12. Interestingly, overcomplementation of these phenotypes is observed in the M. tuberculosis ⌬Rv1813c mutant expressing both Rv1813c and Rv1812c, but not Rv1813c alone, in trans. Therefore, Rv1813c and Rv1812c may represent general stress-responsive elements that are necessary for aspects of M. tuberculosis virulence and the host immune response to infection.
A
lthough Mycobacterium tuberculosis has been recognized as a significant human pathogen for more than 100 years, the global burden of disease caused by this bacterium continues to be high. It is estimated that M. tuberculosis latently infects one-third of the world's population. In 2009 alone, infection by M. tuberculosis was responsible for approximately 9 million new cases of tuberculosis and 2 million deaths (68) . Although latently infected individuals are largely asymptomatic and noncontagious, the ability of M. tuberculosis to enter a state of nonreplicating persistence and reactivate during periods of immune suppression make these individuals potent reservoirs for potential disease reactivation and transmission. The continued increase in multidrug-resistant (MDR) and extensively drug-resistant (XDR) variants of M. tuberculosis further compromises our ability to successfully control infection (15, 19, 68) . Understanding the mechanisms by which M. tuberculosis persists is therefore crucial for the development of novel antimycobacterial drugs and/or therapeutics capable of targeting M. tuberculosis during latency.
Following transmission to naive hosts, M. tuberculosis infects alveolar macrophages, where the bacterium inhibits steps in phagosome maturation to establish a protected replication niche within membrane-bound vesicles (1, 44) . Most often, infection leads to generation of a successful adaptive immune system response, culminating in the generation of productive granulomatous lesions at infection sites. It has long been thought that granulomas act to limit dissemination of the bacterium from the initial infection site; however, recent evidence suggests granulomas are highly dynamic and also promote bacterial dissemination (17) . Within the granuloma, M. tuberculosis is likely exposed to multiple environmental stressors, including reduced oxygen tension, altered nutrient availability, reactive oxygen and nitrogen intermediates, pH alterations, and cell wall/membrane perturbants. To respond to diverse environmental signals, M. tuberculosis encodes numerous regulatory proteins, including 11 complete two-component signal systems (TCSS). Two of these TCSSs in particular, MprAB and DosRS-DosT (also known as DevRS-Rv2027c), have been implicated in aspects of M. tuberculosis persistence in vitro and in vivo (8, 9, 14, 34, 42, 47, 55, 69) .
MprAB is necessary for the establishment and maintenance of persistent infection by M. tuberculosis within the lungs and spleens of infected mice (69) . Genes encoding this TCSS are part of an in vivo-expressed genomic island of 49 genes that are upregulated in the lungs of mice during acute and chronic stages of infection (60, 61) . Expression of mprAB is also upregulated following infection of M. tuberculosis within macrophages (25) and during growth of M. tuberculosis within an artificial hollow-fiber granuloma model system (32) . Activation of MprAB occurs in the presence of cell wall/membrane-damaging agents, nutrient limitation, alkaline pH, and other stresses (6, 27, 47, 66) . Importantly, MprA participates in a positive feedback loop with the extracytoplasmic function (ECF) sigma factor SigE, perpetuating the ability of M. tuberculosis to respond to cell wall/membrane stress and other environmental cues (27, 40, 41, 47, 59, 66, 67) . Once activated, MprAB regulates expression of Ͼ200 genes, including direct regulation of the HtrA-like serine protease pepD, sigma factors sigB and sigE, and the ␣-crystallin-like gene acr2 (27, 28, 46, 47, 66) .
The DosRS-DosT TCSS positively regulates a 48-gene regulon required for nonreplicating persistence and anaerobic dormancy in vitro (2, 3, 8-11, 16, 34, 50) . This system is activated following exposure of M. tuberculosis to multiple environmental stimuli, including hypoxia (55) , nitric oxide (65) , carbon monoxide (33, 57) , and ascorbate (vitamin C) (29, 62) . DosR recognizes an 18-or 20-bp inverted repeat element which is present in at least two copies upstream of its own operon (Rv3134c-dosR-dosS) and most other transcriptional units within this regulon (10, 11, 50) . Apart from the in vitro conditions described above, dosRS and genes from this regulon are also upregulated in several in vitro cell culture infection models (16, 25, 53) and within mice (54, 56) . Importantly, dosRS-dosT mutants of M. tuberculosis are attenuated for virulence in several animal model systems (14, 39) , although this remains controversial (5, 48, 51) . Additionally, several DosRregulated proteins are recognized by the immune system of M. tuberculosis-infected individuals, implicating this TCSS in aspects of infection in humans (7, 21, 36, 37) .
Previous studies by our laboratory and others have indicated that a subset of DosRST-regulated genes is also regulated by MprAB (26, 27, 47) . Therefore, these determinants may represent general stress-responsive genes necessary for growth and/or survival of M. tuberculosis under various conditions. One of these genes, Rv1813c, encodes a conserved hypothetical protein with unknown function. Here, we have carried out an initial characterization of Rv1813c in M. tuberculosis, including its regulation by MprAB and DosRST. Results from these studies indicate that Rv1813c and the downstream gene Rv1812c are cotranscribed and coregulated by both MprAB and DosRST. In addition, infection studies carried out with M. tuberculosis derivatives altered in Rv1813c and/or Rv1812c expression indicate that Rv1813c and possibly Rv1812c regulate aspects of M. tuberculosis virulence in vivo, including the immune response to infection.
MATERIALS AND METHODS
Bacterial strains, media, and growth conditions. All strains, plasmids, and mycobacteriophages used in the study are described in Table 1 . Escherichia coli Top10 (Invitrogen, Carlsbad, CA) or DH5␣ was used for cloning, and E. coli HB101 was used as a transduction host for generating phasmids. E. coli BL21(DE3)/pLysS (Novagen, La Jolla, CA) was used to overexpress and purify recombinant proteins following induction with isopropyl-␤-D-thiogalactopyranoside (IPTG; Invitrogen, Carlsbad, CA). All E. coli strains were grown in Luria-Bertani (LB) broth or on LB agar (Thermo Fisher Scientific, Waltham, MA) supplemented with 100 g/ml ampicillin (Thermo Fisher Scientific, Waltham, MA), 50 g/ml kanamycin sulfate (Thermo Fisher Scientific, Waltham, MA), 150 g/ml hygromycin B (AG Scientific, San Diego, CA), or 25 g/ml chloramphenicol (Thermo Fisher Scientific, Waltham, MA) when necessary. Mycobacterium strains used in this study are derivatives of Mycobacterium tuberculosis H37Rv (ATCC 27294) or Mycobacterium smegmatis mc 2 155 (ATCC 700084). Mycobacterium strains were grown with shaking (150 rpm) at 37°C in Middlebrook 7H9 broth (Difco, Franklin Lakes, NJ) or on Middlebrook 7H10 agar medium (Difco, Franklin Lakes, NJ) supplemented with 0.5% glycerol, 10% albumin-dextrose-catalase (ADC) or oleic ADC (OADC) supplement (Difco, Franklin Lakes, NJ), and 0.05% Tween 80 (Sigma, St. Louis, MO) unless otherwise noted. When required, mycobacterial medium was supplemented with 25 g/ml kanamycin sulfate (Thermo Fisher Scientific, Waltham, MA) or 50 g/ml hygromycin B (AG Scientific, San Diego, CA). Mycobacteriophage production and transduction of M. tuberculosis H37Rv have been described previously (4) . Electrocompetent cells of M. tuberculosis were prepared as described previously (30) .
DNA manipulations. Restriction enzyme digests, cloning, subcloning, and DNA electrophoresis were done according to standard techniques (52) . Oligonucleotides and primers were synthesized by Eurofins MWG Operon (Huntsville, AL) and are listed in Table S1 in the supplemental material. PCR was performed using Platinum PCR Supermix High Fidelity, Platinum Pfx, or Taq polymerase (Invitrogen, Carlsbad, CA). All amplified products were cloned into pCR2.1-TOPO (Invitrogen, Carlsbad, CA) and sequenced to confirm the absence of mutations. Cloned inserts were then removed by restriction enzyme digestion, resolved on a 1% agarose gel, recovered by gel purification, and subcloned into the appropriate vector. Ligations were performed using the Quick Ligation kit (New England BioLabs, Beverly, MA) or T4 DNA ligase (Invitrogen, Carlsbad, CA). When necessary, plasmid DNA was treated with Antarctic phosphatase (New England BioLabs, Beverly, MA) to prevent religation of vector ends. Electroporation of plasmid DNA into Mycobacterium was conducted as previously described (30) . Plasmid DNA was prepared using the QIAprep Spin Miniprep kit (Qiagen, Venlo, The Netherlands) as recommended by the manufacturer. DNA fragments were purified using either a QIAquick gel extraction kit or QIAquick PCR purification kit (Qiagen, Venlo, The Netherlands). DNA sequencing was performed with an ABI Prism BigDye Terminator cycle sequencing ready reaction kit (Applied Biosystems, Carlsbad, CA) using an automated long capillary method (ABI Prism 3100 Genetic Analyzer; Applied Biosystems, Carlsbad, CA).
Extraction of DNA and RNA. Mycobacterial genomic DNA was isolated as described previously (30) . For isolation of RNA, M. tuberculosis was grown in 7H9 broth to mid-log phase (optical density at 600 nm [OD 600 ] of 0.5). For some assays, bacterial cultures were exposed to 100 M diethylenetriamine/nitric oxide (DETA/NO; Sigma-Aldrich, St. Louis, MO) for 40 min to induce activation of DosRST (65) or 0.05% sodium dodecyl sulfate (SDS; Thermo Fisher Scientific, Waltham, MA) for 90 min to induce activation of MprAB (27) . RNA was fixed by treating cultures with RNAlater (Ambion, Austin, TX) at least overnight at 4°C prior to processing. Bacteria were collected by centrifugation, washed twice with 1ϫ phosphate-buffered saline (PBS), and then mechanically disrupted in the presence of RNA-Bee (Tel-Test, Friendswood, TX) by bead beating. RNA was then extracted with chloroform, precipitated with isopropanol, and stored at Ϫ20°C until use. Resulting RNA was resuspended in diethylpyrocarbonate (DEPC)-treated water, treated with Turbo DNase (Ambion, Austin, TX) to remove contaminating genomic DNA, and purified using an RNeasy Miniprep column (Qiagen, Valencia, CA).
EMSAs and DNase I protection assays. Electrophoretic mobility shift assays (EMSAs) and DNase I protection studies were conducted essentially as described previously (28) . For EMSAs, probes were generated by amplification from the genome of M. tuberculosis H37Rv, and for some studies oligonucleotides were synthesized by Eurofins MWG Operon (Huntsville, AL). Probes were end labeled with [␥-32 P]ATP (MP Biomedical, Solon, OH) using T4 polynucleotide kinase (Invitrogen, Carlsbad, CA). Approximately 5 ng of labeled probes (15,000 to 20,000 cpm) was incubated with various concentrations of His-MprA (60 to 120 pmol) (70) or His-DosR (1.5 to 52 pmol) (27) for 20 min in reaction buffer containing 20 mM KCl, 5% glycerol, 10 ng/ml salmon sperm DNA, 25 mM Tris-HCl (pH 8.0), 6 mM MgCl 2 , 0.5 mM EDTA, 0.5 mM dithiothreitol (DTT), and 4.0 g of poly(dI-dC). Following incubation, reaction mixtures were loaded onto a 5% nondenaturing polyacrylamide gel, electrophoresed at 130 V for 2.5 to 3.0 h at 4°C, dried, and exposed to Biomax (Kodak, Rochester, NY) X-ray film at Ϫ80°C overnight. For some experiments, excess (150-and 300-fold) cold DNA from the same region or from a different DNA region was included in reactions to demonstrate binding specificity. For DNase I protection studies, DNA probes were PCR amplified from M. tuberculosis H37Rv and cloned into pCR2.1-TOPO (Invitrogen, Carlsbad, CA). Resulting plasmids were digested with MluI and EcoRI and separated on an agarose gel to resolve the DNA probes. Probes were purified and radiolabeled with [␣-32 P]dCTP (MP Biomedical, Solon, OH) using Klenow. Seventy ng of labeled DNA was then incubated at room temperature for 20 min with either purified HisMprA or His-DosR as described for EMSAs. Binding reactions were treated with 0.4 U DNase I for 2 min at room temperature and then stopped by addition of 2ϫ stop solution (200 mM NaCl, 30 mM EDTA, and resolved on a 6% denaturing polyacrylamide gel for ϳ2.0 h at 60 W alongside a DNA sequencing ladder prepared using the Thermo Sequenase cycle sequencing kit (Affymetrix, Santa Clara, CA). Gels were dried and exposed to Biomax MR X-ray film as was done for EMSAs. MEME analysis. Predicted binding sites for MprA were determined using MEME (Multiple Em for Motif Elicitation; http://meme.sdsc.edu).
qRT-PCR and 5=-RACE. For quantitative reverse transcription-PCR (qRT-PCR), cDNA samples from M. tuberculosis strains were prepared by incubating 500 ng total RNA with random M. tuberculosis decamers (18) in a reverse transcription reaction mixture containing SuperScript III reverse transcriptase (Invitrogen, Carlsbad, CA). To test for the presence of DNA contamination, identical reaction mixtures lacking SuperScript III were also run. For cotranscription studies, reactions included primer sets that spanned the Rv1813c-Rv1812c intergenic region. Amplification conditions consisted of 30 rounds of denaturation at 95°C for 30 s, annealing at 56°C for 30 s, and extension at 72°C for between 30 s and 2 min. Reactions were run on an MJ Research PTC-200 thermocycler (Bio-Rad, Hercules, CA). For qRT-PCR, reactions included primer sets that amplified 100-to 150-bp fragments from specific coding sequences or ϳ325-bp fragments for the Rv1813c-Rv1812c intergenic region. Amplification conditions consisted of 40 rounds of denaturation at 95°C for 30 s and annealing/extension at 60°C for 15 s using iQ SYBR green Supermix (BioRad, Hercules, CA). Reactions were run on an iCycler iQ real-time PCR detection system (Bio-Rad, Hercules, CA). Single PCR products were confirmed by performing a postamplification melting curve analysis for each reaction. For relative quantification of transcript levels, target genes were normalized to the ribosomal gene rrs. For absolute quantification of transcript levels, target genes were compared to a DNA standard curve generated from known concentrations of M. tuberculosis H37Rv DNA. For 5= rapid amplification of cDNA ends (RACE), the FirstChoice RLM-RACE kit (Applied Biosystems, Austin, TX) was used essentially as recommended by the manufacturer. Briefly, 3 to 5 g of total RNA was ligated to 300 ng of 5= RACE adaptor using 5 U of T4 RNA ligase (Applied Biosystems, Austin, TX) for 1 h at 37°C. RNA was then reverse transcribed with M. tuberculosis-specific decamers and Moloney-murine leukemia virus (MMLV) reverse transcriptase (Applied Biosystems, Austin, TX) for 1 h at 50°C. PCR was then performed using a primer nested within the gene of interest and a primer specific to the 5= RACE adaptor (5= RACE inner primer). Resulting PCR products were cloned into pCR2.1-TOPO and sequenced using the M13rev primer. When possible, 10 to 20 clones were sequenced for each primer set.
␤-Galactosidase reporter assays. The Rv1813-lacZ reporter was generated by amplifying the region upstream of Rv1813c from M. tuberculosis H37Rv (from Ϫ415 to ϩ79 relative to the Rv1813c translational start site) and subcloning into pJEM15 (63) , resulting in vector pTZ1016. This plasmid was subsequently introduced into wild-type M. tuberculosis or M. smegmatis or the isogenic ⌬mprAB or ⌬dosR strain. Resulting strains were grown in 7H9 medium to mid-log phase (OD 600 of 0.5), washed three times in 1ϫ PBS, suspended in lysis buffer (300 mM Tris [pH 6.8], 100 mM NaCl, and 5 mM EDTA), and mechanically lysed using a bead beater (BioSpec Products, Bartlesville, OK). Cell debris was separated from the whole-cell lysate by centrifugation. ␤-Galactosidase assays and quantification were carried out as previously described (26) .
Construction of M. smegmatis and M. tuberculosis deletion mutants and complemented strains. The M. smegmatis ⌬mprAB mutant has previously been described (66) . The whole coding region of dosR (MSMEG_5244) in M. smegmatis mc 2 155 was deleted using a standard two-step homologous recombination procedure as described previously (4) . Briefly, the counterselectable marker sacB was amplified from pYUB870 and cloned into the Mycobacterium suicide vector pYUB854 to generate pTZ898. Regions (1.0 kb) upstream and downstream of the dosR coding sequence were then amplified from M. smegmatis mc 2 155 genomic DNA and cloned into pTZ898. The resulting plasmid was electroporated into wild-type M. smegmatis mc 2 155 to generate a ⌬dosR derivative. Resulting recombinants were screened by PCR to confirm gene loss (data not shown).
Deletion mutants of M. tuberculosis were generated by specialized transduction essentially as described previously (4) . Briefly, 1.0-kb regions upstream and downstream of the Rv1813c coding sequence were PCR amplified from M. tuberculosis H37Rv genomic DNA using Rv1813cKupF and Rv1813cKupR (upstream region) as well as Rv1813cKdownF and Rv1813cKdownR (downstream region). PCR products from each reaction were cloned into pCR2.1-TOPO, sequenced to confirm the absence of mutations, digested with the appropriate restriction enzymes, and directionally subcloned into the corresponding sites flanking the res-hyg-res cassette present in pYUB854 (4). The resulting plasmid, pTZ779, was digested with PacI, ligated to PacI-digested concatemers of phAE87, and packaged into heads using the GIGAPackIII in vitro -packaging system (Agilent Technologies, Santa Clara, CA). Resulting phage particles were transduced into E. coli HB101, and hygromycinresistant transformants were selected. Plasmid DNA was prepared from pooled transductants and electroporated into M. smegmatis mc 2 155 at the permissive temperature of 30°C, and resulting plaques were purified and screened at the nonpermissive temperature of 38°C to verify the temperature-sensitive phenotype. High-titer specialized transducing phage lysates were then prepared and used to transduce M. tuberculosis H37Rv at the nonpermissive temperature using a multiplicity of infection (MOI) of 10:1 (phage:bacteria). Hygromycin-resistant transductants were grown for 3 to 4 weeks, restreaked onto selective medium, and screened for the desired allelic exchange event by PCR. Confirmed deletion mutants were unmarked by electroporation with pYUB870 (4). Following counterselection on medium containing 10% sucrose, resulting sucrose-resistant, kanamycin-sensitive, and hygromycin-sensitive recombinants were screened for unmarking of the Rv1813c mutation by PCR. The resulting strain, TB79 (⌬Rv1813c), was complemented with either Rv1813c alone or the entire Rv1813c-Rv1812c locus. For single-gene complementation, the Rv1813c coding region, including 400 bp of sequence upstream of the translational start site, was amplified from M. tuberculosis H37Rv genomic DNA with primers Rv1813cinpMV306Fwd and Rv1813cinpMV306Rev and subcloned into pMV306 (58) , resulting in pTZ972. For complementation with both genes, the Rv1813c-Rv1812c coding region, including the 400 bp of upstream sequence, was amplified with primers Rv1813cinpMV306Fwd and RevEcoRI1812cpMV306 and subcloned into pMV306, resulting in pTZ1263. Plasmids were electroporated into TB79, resulting in strains TB99 (TB79/pTZ1263) and TB108 (TB79/pTZ972). TB79 was also complemented with either Rv1813c alone or Rv1812c under the control of the heterologous, constitutively expressed hsp60 promoter. The Rv1813c or Rv1812c opening reading frame was amplified from M. tuberculosis H37Rv genomic DNA with primers EcoRI1813F-361 and Rv1813cinpMV306Rev or EcoRI1812F-361 and R-EcoRI1812cpMV306, respectively. Products were cloned into pMV361 (58) behind the hsp60 promoter, resulting in pTZ1286 (hsp60-Rv1813c) and pTZ1287 (hsp60-Rv1812c). Plasmids were electroporated into TB79, resulting in strains TB246 (TB79/pTZ1286) and TB247 (TB79/pTZ1287). All strains were verified by PCR (data not shown).
In vitro survival assays. To assess survival of M. tuberculosis derivatives under oxygen-limiting conditions, strains were grown to mid-log phase (OD 600 of 0.3 to 0.4) and diluted to an OD 600 of 0.02 in 10 ml fresh 7H9 medium. Cultures were then transferred to tightly sealed 15-ml conical tubes and incubated at 37°C without shaking. At various times postinoculation, bacteria were serially diluted and aliquots plated onto 7H10 agar medium for CFU determination. Independent tubes were processed for each strain at each time point to prevent introduction of oxygen into growth medium during sampling. The rapid anaerobic dormancy (RAD) model has been described elsewhere (34) . To assess survival against cell wall/membrane stress, M. tuberculosis derivatives were grown to mid-log phase in 7H9 medium and exposed to SDS at a final concentration of 0.4%. Bacteria were incubated at 37°C with shaking, and aliquots were processed at 0, 2, 4, and 8 h postexposure. CFU were quantified as described above. For survival under oxidative stress, cultures were initially grown to an OD 600 of 0.1 in 7H9 supplemented with OADC. Bacteria were then washed three times with 1ϫ PBS and resuspended in 10 ml 7H9 supplemented with ADC to eliminate any effect of catalase present in the OADC supplement. Hydrogen peroxide was added to cultures at a final concentration of 1 or 10 mM, and cultures were incubated at 37°C with shaking for an additional 8 h. Following incubation, cultures were removed and serially diluted, and aliquots were plated onto 7H10 agar medium to quantify CFU.
Macrophage infection assays. The murine macrophage-like cell line J774A.1 (ATCC TIB-67) was maintained in Dulbecco's modified Eagle medium (DMEM) (Lonza, Basel, Switzerland) containing 10% fetal bovine serum (Gemini Bio-Products) and 2 mM L-glutamine (Invitrogen, Carlsbad, CA). The human monocyte-like cell line THP-1 (TIB-202) was maintained in RPMI 1640 (Lonza, Basel, Switzerland) with 10% fetal bovine serum and 2 mM L-glutamine. THP-1 cells were differentiated to macrophages by treatment with 40 ng/ml phorbol 12-myristate 13-acetate (PMA; Sigma, St. Louis, MO) 24 h prior to infection. All cells were incubated at 37°C in 5% CO 2 and humidified air. For infections, J774A.1 or differentiated THP-1 cells were seeded in 12-well tissue culture plates at a density of 1 ϫ 10 5 or 2 ϫ 10 5 cells/well, respectively. M. tuberculosis strains were grown to mid-log phase (OD 600 of 0.6 to 0.8), washed with 1ϫ PBS, and suspended in the appropriate tissue culture medium. Single-cell suspensions of M. tuberculosis derivatives were then generated by vortexing cultures with 3-mm glass beads and allowing bacterial aggregates to settle overnight at 4°C. An aliquot was removed from the upper layer of each culture, and bacteria were enumerated using the BacLight bacteria viability kit (Invitrogen, Carlsbad, CA). M. tuberculosis was diluted in tissue culture medium to reach an MOI of 10:1 (bacteria:cells). Macrophages were allowed to ingest bacteria for 2 h before cells were washed with 1ϫ PBS to remove extracellular bacilli. Infected macrophages were lysed at various times postinfection with sterile water containing 0.05% Tween 80 and serially diluted in 1ϫ PBS with 0.05% Tween 80, and CFU were determined by plating on 7H10 agar medium.
Virulence of M. tuberculosis in a low-dose aerosol model of murine tuberculosis. Six-to 8-week-old female BALB/c mice (Taconic, Hudson, NY) or BALB/c SCID mice (Jackson Laboratory, Bar Harbor, ME) were infected with M. tuberculosis strains using an inhalation exposure system (Glas-Col, Terra Haute, IN). For infections, bacterial strains were grown in 7H9 medium to mid-log phase (OD 600 of 0.6 to 0.8) and processed in a manner similar to that described for macrophage infections. Enumerated bacterial suspensions were diluted in 1ϫ PBS to allow final deposition of ϳ100 CFU per mouse lung (inoculum dose of ϳ2.0 ϫ 10 5 CFU/ml). Five ml of the diluted bacterial suspension was added to the glass nebulizer and the exposure program initiated. Exposure parameters included a 15-min preheat, 30-min nebulization, 30-min cloud decay, and 15-min decontamination with compressed airflow at ϳ15 cubic feet per h and a vacuum setting of ϳ50 cubic feet per h. Animals were housed in microisolation cages (Allentown Inc., Allentown, NJ) following infection and were provided food and H 2 O ad libitum. At various times postinfection, mice were sacrificed and lung, spleen, and liver aseptically removed. Tissues were homogenized in 1ϫ PBS, and the bacterial burden in each organ was assessed by CFU determination on Middlebrook 7H9 supplemented with 1.5% agar (Difco, Franklin Lakes, NJ), 0.5% glycerol, 10% OADC, and 0.05% Tween 80. A portion of the lung and spleen from a representative mouse in each experimental group was also reserved for histology. Groups of five BALB/c SCID mice were infected simultaneously in the same chamber with BALB/c mice to determine the lethality of each M. tuberculosis strain by time-to-death assays. For these studies, three BALB/c SCID mice were left uninfected and served as negative controls, surviving the length of the experiment. Mice were observed daily for 115 days or until they became visually moribund, at which point they were euthanized. All ani- Statistical analysis. In general, a Student's t test was used to determine statistical differences. To determine statistical differences in organ burden and time to death following aerosol infection, a Mann-Whitney and logrank (Mantel-Cox) test was used, respectively.
RESULTS
MprA directly regulates Rv1813c. DNA microarray and qRT-PCR expression studies have previously indicated that MprA regulates genes from the DosR regulon in M. tuberculosis (27, 47, 55, 65) . One of these genes, Rv1813c, encodes a conserved hypothetical protein and is downregulated ϳ2-to 3-fold in an mprA::Km r mutant relative to wild-type M. tuberculosis under various conditions (27) . Rv1813c lays in a locus along with Rv1812c, encoding a predicted type II NADH dehydrogenase, and the divergently transcribed erg3 (Rv1814), encoding a predicted C-5 desaturase (Fig.  1A) . To determine whether MprA regulated Rv1813c via a direct mechanism, EMSAs were conducted with His-MprA using DNA probes generated to the Rv1813c upstream region. Overlapping probes were used due to the large intergenic region between Rv1813c and erg3 (409 bp) (Fig. 1A) . His-MprA retarded the mobility of the DNA probe from the region distal to the Rv1813c translational start site (probe 1; Ϫ411 to Ϫ139) (Fig. 1B, lanes 1 to  4) but failed to interact with the probe proximal to the Rv1813c coding sequence (probe 2; Ϫ209 to ϩ51) (data not shown). Interaction of His-MprA with probe 1 was sequence specific, as the inclusion of excess cold DNA from probe 1 (Fig. 1B, lanes 5 to 7) but not probe 2 (Fig. 1B, lanes 8 to 10) competed off labeled DNA from the protein. As probe 1 also included sequences predicted to be recognized by DosR (10), EMSAs were repeated to confirm direct binding by His-DosR to this region. As expected, His-DosR bound to the Rv1813c distal region (Fig. 1C, lanes 1 to 5) and could be competed off using excess cold DNA from the same region (Fig.  1C, lanes 8 and 9) or excess cold DNA from the promoter region of another DosR-regulated gene, acr (Fig. 1C, lanes 6 and 7) . In contrast, binding by His-DosR to radiolabeled probe 1 was not abrogated by the addition of excess cold DNA from the Rv1813c proximal region (Fig. 1C, lanes 10 and 11) . Therefore, regulation of Rv1813c by MprA and DosR occurs via a direct mechanism.
Characterization of the Rv1813c promoter region. To determine sequences within the Rv1813c upstream region important for MprA binding, DNase I footprinting assays were carried out. His-MprA protected an ϳ28-bp region extending from Ϫ241 to Ϫ214 relative to the Rv1813c translational start site ( Fig. 2A) . Regions of DNase I hypersensitivity were also identified just outside the protected region, a characteristic commonly seen with MprAregulated promoters (27, 28) , likely indicating bending of DNA by this protein (Fig. 2A) . Phosphorylated DosR or the C-terminal DNA binding domain of DosR has previously been shown to bind two well-conserved primary recognition motifs upstream of the Rv1813c translation start site (P1, Ϫ304 to Ϫ287; P2, Ϫ272 to Ϫ254), one less conserved secondary recognition motif (S, Ϫ252 to Ϫ235), and an extended region of recognition (E, Ϫ234 to Ϫ218) (10). To determine if unphosphorylated His-DosR protected a similar region, DNase I protection assays were repeated with His-DosR using the same DNA probe as that used for HisMprA. His-DosR protected a 73-bp region extending from Ϫ304 to Ϫ232 relative to the translation start site and also induced regions of DNase I hypersensitivity (Fig. 2B) . Therefore, unphosphorylated His-DosR protects the primary and secondary sites previously identified (10) but fails to protect sequences in the extended region.
To identify potential MprA recognition motifs in the Rv1813c upstream sequence, the DNA region protected by MprA was subjected to MEME analysis against known MprA binding sites, including those upstream of mprA, sigB, sigE, pepD, and Rv0081 (27, 28) . Two potential MprA binding motifs separated by only 2 bp were identified in this region (TTTATC-N 5 -CTTGGG and TATC GC-N 5 -TGGGCA) (Fig. 2C ). While the originally described motif was still visible in both sequences, further emphasis was placed on the conserved thymines located at positions T 1 , T 3 , T 12 , and T 14 (Fig. 2C) . To delineate the importance of these residues, EMSAs were repeated with His-MprA using two 60-bp DNA probes (Fig.  2D ) in which the predicted recognition motifs were either left intact (probe 3) or were altered to incorporate nucleotide changes at several of these conserved thymines (probe 4). While His-MprA retarded the mobility of the wild-type probe as expected (Fig. 2E) , binding by His-MprA was not observed with the probe containing the nucleotide substitutions (Fig. 2F) . Thus, MprA binds a 17-bp loosely conserved direct-repeat recognition motif that contains thymines at highly conserved positions.
To identify the transcriptional start point (TSP) of Rv1813c, 5= RACE was conducted using M. tuberculosis H37Rv RNA prepared from cultures grown under physiological conditions or cultures that were exposed to subinhibitory concentrations of SDS or DETA/NO to activate MprAB and DosRST, respectively. Multiple gene-specific primers were used in these assays to minimize the identification of false start sites. In wild-type M. tuberculosis H37Rv, a single TSP at position Ϫ218 (adenine) relative to the translational start was identified (Fig. 3A and data not shown) . M. tuberculosis exposed to SDS or DETA/NO also produced an Rv1813c transcript initiating at position Ϫ218 (data not shown). To determine whether MprA and DosR both promoted transcription from this TSP, 5= RACE was repeated utilizing RNA isolated from M. tuberculosis ⌬mprAB and ⌬dosR mutants. In M. tuberculosis ⌬mprAB and ⌬dosR mutants, a predominant TSP at position Ϫ218 was again identified (data not shown). Less abundant transcripts initiating at alternative TSPs were not consistently observed. Thus, Rv1813c transcription initiates at Ϫ218 relative to the translational start site (Fig. 3A) , and this promoter element is utilized by both DosR and MprA under physiological conditions and following exposure to specific stress. 5= RACE was also utilized to determine whether a TSP was present immediately upstream of Rv1812c. Using reverse primers positioned near the beginning of the Rv1812c coding sequence, a predominant TSP was identified at Ϫ113 relative to the translational start site for this gene (data not shown). Thus, Rv1812c transcription is initiated from a promoter within the Rv1813c-Rv1812c intergenic region.
Finally, to assess the relative contribution of MprAB and DosRST to Rv1813c expression, an M. tuberculosis Rv1813c promoter-lacZ reporter fusion was generated and introduced into wild-type M. tuberculosis H37Rv or mutant derivatives carrying unmarked deletion mutations in mprAB or dosR. While moderate levels of ␤-galactosidase activity were observed in wild-type M. tuberculosis, enzyme levels were significantly lower in strains deleted of mprAB or dosR (Fig. 3B) . The drop in ␤-galactosidase activity in the M. tuberculosis ⌬dosR mutant was significantly greater than that observed with M. tuberculosis ⌬mprAB (Fig. 3B ). These data were further supported by qRT-PCR (data not shown). Interestingly, despite the absence of the Rv1813c-Rv1812c locus in the often utilized nonpathogenic Mycobacterium surrogate Mycobacterium smegmatis (see Fig. S1 in the supplemental material), the pattern of ␤-galactosidase activity produced by these strains was largely consistent with those observed in M. tuberculosis ( 5) , or with fixed amounts of His-DosR and increasing amounts of specific (acr, lanes 6 and 7, or probe 1, lanes 8 and 9) or nonspecific (probe 2, lanes 10 and 11) cold competitor DNA. The amount of His-DosR used in binding reactions was 1.5, 15, 37, and 52 pmol in lanes 2 to 5, respectively. The amount of His-DosR used in lanes 6 to 11 was 37 pmol. Competitor DNA was added at a 10-or 100-fold molar excess of labeled DNA. B, protein-bound probe; F, free probe. 3C). Thus, MprA and DosR are capable of mediating Rv1813c regulation in other Mycobacterium species in which this determinant is absent.
Construction and characterization of M. tuberculosis H37Rv ⌬Rv1813c mutant and complemented strains. To assess the importance of Rv1813c in M. tuberculosis physiology and virulence, the Rv1813c coding region was deleted in M. tuberculosis H37Rv by specialized transduction (4) . Following unmarking, the ⌬Rv1813c mutant (TB79) was complemented in trans in single copy with either Rv1813c alone (TB108) or with Rv1813c-Rv1812c Wild-type probe (probe 3) and mutant probe in which the key thymine residues were altered to cytosines (probe 4) were generated. Shaded areas indicate the loosely conserved direct repeats. His-MprA bound probe 3 (E) but failed to bind probe 4 (F). Concentrations of labeled DNA probe and His-MprA were identical to those used in Fig. 1B, lanes 1 to 4. (TB99). Complementation vectors included ϳ400 bp of sequence upstream of the Rv1813c translational start site that included the promoter element and the binding sites for both MprA and DosR. All generated mutant and complemented mutant derivatives were confirmed by PCR (data not shown).
To examine expression of Rv1813c and Rv1812c in mutant and complemented mutant derivatives, M. tuberculosis strains were grown to early log phase in 7H9 medium and subjected to qRT-PCR. Expression levels of each gene were first normalized to the ribosomal gene rrs, and then relative expression levels were compared to expression levels in wild-type H37Rv, which was set to 1.0 (Fig. 4A) . Expression of Rv1813c was not detectable in TB79, as expected (Fig. 4A) . Importantly, expression of Rv1812c in this strain was similar to that observed in H37Rv, demonstrating that Rv1813c deletion is not polar upon Rv1812c expression (Fig. 4A) . In contrast, expression levels of Rv1813c in complemented mutants TB99 and TB108 were approximately 1.9-and 3.7-fold lower, respectively, than Rv1813c expression levels in H37Rv (Fig.  4A) . While the reasons for this are unclear, it is possible that expression of this gene is lower when positioned at the attB site compared to its native location. Additionally, while Rv1812c expression in TB108 was comparable to that seen in H37Rv, expression of this gene in TB99 was approximately 2.5-fold greater than its expression in wild-type H37Rv (Fig. 4A) , likely reflecting the presence of two copies of Rv1812c in this strain.
While 5= RACE studies indicated that Rv1813c and Rv1812c 
FIG 4 RT-PCR determining expression levels of Rv1813c and Rv1812c in
H37Rv, TB79, TB99, and TB108. (A) RNA was isolated from exponentially growing cultures, and relative expression was determined utilizing primers specific for each gene. Relative expression was determined based on biological triplicates for each gene, normalizing each reaction to expression of rrs and calculating the fold expression levels compared to H37Rv expression of each gene, which was set to 1.0. (B) Primers specific for Rv1812c, Rv1813c, or spanning the Rv1813c-Rv1812c intergenic region were used to amplify cDNA generated from RNA isolated from exponentially growing cultures of H37Rv and TB79 with (ϩRT) or without (ϪRT) reverse transcription. Primers specific for sigA serve as a control. Absolute quantification of transcripts containing sigA, Rv1813c, Rv1812c, or Rv1813c-Rv1812c were determined by RT-PCR using RNA isolated from M. tuberculosis H37Rv cultures with or without 100 M DETA/NO treatment. (C) Copy number was determined by comparison to a DNA standard curve generated using genomic DNA from wild-type M. tuberculosis and gene-specific primer sets. ND, not detected.
were independently transcribed, published studies from other groups have also indicated that Rv1812c expression is regulated by DosR and/or conditions leading to DosR activation (33, 50, 55, 65) . To qualitatively assess potential cotranscription of Rv1813c and Rv1812c, RT-PCRs were carried out on RNA from wild-type M. tuberculosis using primer sets specific to Rv1813c and Rv1812c or a primer set that amplified the intergenic region between these genes. PCR products of the expected sizes were observed with each primer set in reaction mixtures containing DNA or RNA which had been reverse transcribed but not in reaction mixtures lacking reverse transcriptase or template (Fig. 4B) . Importantly, PCR products were not detected from TB79 RNA with primer sets that amplified sequences from Rv1813c (Fig. 4B) . Thus, Rv1813c and Rv1812c are cotranscribed under physiological conditions. To quantify the abundance of transcripts carrying Rv1813c, Rv1812c, or both, qRT-PCR was carried out and absolute copy numbers determined by generating standard curves using 10-fold serial dilutions of M. tuberculosis H37Rv genomic DNA and gene-specific primer sets (Fig. 4C) . Under physiological conditions, transcripts containing Rv1813c or Rv1812c were detected at levels slightly lower than those observed for the constitutively expressed sigma factor sigA. Notably, transcripts containing both Rv1813c and Rv1812c were also detected, albeit at significantly lower levels than transcripts containing either Rv1813c or Rv1812c. However, following exposure of M. tuberculosis to DETA/NO, the number of transcripts containing Rv1813c, Rv1812c, or Rv1813c-Rv1812c increased. Of importance, following DETA/NO exposure transcripts containing Rv1813c-Rv1812c were elevated approximately 1,000-fold above levels seen in M. tuberculosis grown under physiological conditions (Fig. 4C) . In contrast, levels of sigA were unaltered by DETA/NO treatment, indicating that the increase in Rv1813c-Rv1812c cotranscription was not due to a global increase in transcription. Thus, Rv1813c and Rv1812c are transcribed independently but can also be cotranscribed, particularly under conditions inducing activation of DosR. Deletion of Rv1813c alters growth of M. tuberculosis in vitro. To assess whether deletion of Rv1813c altered growth of M. tuberculosis in vitro, the ⌬Rv1813c mutant and complemented mutant derivatives were cultured in 7H9 and growth was monitored by optical density and/or CFU. When cultures were agitated, the ⌬Rv1813c mutant (TB79) exhibited a consistently increased growth rate and reached a higher optical density than the wildtype parent (Fig. 5A) . The observed increase in optical density correlated with a general increase in CFU (data not shown). Interestingly, complementation of ⌬Rv1813c with Rv1813c-Rv1812c (TB99) but not Rv1813c alone (TB108) restored wild-type growth characteristics to M. tuberculosis ⌬Rv1813c (Fig. 5A) .
To determine whether the failure to complement the growth phenotype in TB108 was due to the lower levels of Rv1813c observed in this strain relative to wild-type H37Rv and TB99, growth curves were carried out on M. tuberculosis ⌬Rv1813c derivatives in which either Rv1813c (TB246) or Rv1812c (TB247) was expressed under the control of the heterologous hsp60 promoter. In these strains, relative expression of Rv1813c or Rv1812c was increased greater than 10-fold compared to wild-type M. tuberculosis (data not shown). While TB247 did not exhibit altered growth characteristics compared to TB79, growth of TB246 was reduced relative to that of TB79. Collectively, these results indicate that the failure of TB108 to display wild-type growth characteristics is due to reduced Rv1813c expression levels in this strain, indicating that a certain threshold of Rv1813c expression is necessary to restore wild-type M. tuberculosis growth levels.
Given the direct coregulation of Rv1813c-Rv1812c by DosR and MprA, growth and/or survival of M. tuberculosis ⌬Rv1813c and complemented mutant strains was also assessed under conditions previously shown to activate DosR or MprA signaling. To activate DosR, strains were grown statically in tightly sealing tubes (64) . Under these conditions, all strains grew exponentially during the first 8 days of incubation, followed by a prolonged period of nonreplicating persistence with no significant differences in growth and/or survival between wild-type, mutant, and complemented mutant derivatives observed over the 80-day period analyzed (Fig. 5C ). An alternative model of anaerobic survival, termed the rapid anaerobic dormancy (RAD) model, has also been described (34) . In this model, cultures are grown in sealed tubes with stir bars to rapidly induce a hypoxic state. Consistent with the standing culture model, no significant differences in growth/survival were observed in this culture system (data not shown). For MprA-activating conditions, strains were exposed for various lengths of time to 0.4% SDS, a concentration previously shown to reduce survival of an M. tuberculosis H37Rv ⌬mprAB mutant (66) . Following exposure to SDS, all strains exhibited an equivalent reduction in CFU over the 8 h examined (Fig. 5D) .
Finally, to assess survival of M. tuberculosis under conditions of oxidative stress, M. tuberculosis derivatives were exposed to different concentrations of hydrogen peroxide. While oxidative stress is not known to activate DosRST or MprAB signaling, it is a recognized stimulus encountered by M. tuberculosis in macrophages. No differences in CFU were observed following exposure of M. tuberculosis derivatives to 1 mM hydrogen peroxide (Fig. 5E ). In contrast, exposure to 10 mM hydrogen peroxide resulted in a Ͼ3.0 log reduction in CFU of all strains compared to their untreated controls (Fig. 5E) . However, no significant differences in survival were observed between any of the strains at this hydrogen peroxide concentration (Fig. 5E) . Thus, loss of Rv1813c expression increases replication rates and bacterial densities in M. tuberculosis cultures that were agitated but does not alter growth and/or survival of M. tuberculosis following exposure to other stimuli, including hypoxia, SDS, or H 2 O 2 .
Rv1813c is dispensable for growth of M. tuberculosis in macrophages. The primary cell targeted by M. tuberculosis is the alveolar macrophage. To determine whether deletion of Rv1813c affected intracellular survival of M. tuberculosis, growth characteristics of the ⌬Rv1813c mutant and complemented mutant derivatives were assessed in murine J774A.1 macrophages and differentiated human THP-1 macrophage-like cells. For each cell type, intracellular growth was quantified by determining CFU at various time points postinfection. No significant differences in growth and/or survival between strains were observed following infection of J774A.1 (Fig. 6A) . In THP-1 macrophage-like cells, TB108 achieved a significantly higher cell count than wild-type M. tuberculosis at day 3 postinfection, but at all other times points there was no significant difference between any of the strains (Fig. 6B) . Thus, Rv1813c is dispensable for M. tuberculosis growth within macrophages.
M. tuberculosis ⌬Rv1813c is attenuated for virulence in a low-dose aerosol model of murine tuberculosis. MprA and DosR have been implicated in virulence and/or persistence of M. tuberculosis in vivo (14, 39, 68) . Therefore, we sought to determine the role of Rv1813c in the pathogenesis of M. tuberculosis. Wild-type H37Rv, ⌬Rv1813c, and ⌬Rv1813c complemented with Rv1813c-Rv1812c were infected into BALB/c mice via aerosol exposure, and groups of mice were sacrificed at the indicated time points to enumerate bacterial burdens in the lung, liver, and spleen. While an equivalent number of these M. tuberculosis derivatives was initially deposited in the lungs of animals following infection, the number of M. tuberculosis ⌬Rv1813c mutants recovered at each time point was generally reduced relative to the number of wild-type M. tuberculosis organisms recovered (Fig. 7A) . Importantly, complementation with Rv1813c-Rv1812c restored virulence characteristics of the ⌬Rv1813c mutant to wild-type levels or higher in the lungs of infected animals (Fig. 7A) . A similar trend in altered bacterial burden between M. tuberculosis strains was also observed in the liver (Fig. 7B) and spleen (Fig. 7C) , although the extent of differences between these strains varied between organs and the time point examined. To determine whether the observed differences in CFU affected the time to death in animals, infection assays were simultaneously carried out using immunocompromised BALB/c SCID mice. Animals infected with wild-type M. tuberculosis had a mean time to death of 51 days (Fig.  7D) , while the time to death of mice infected with the ⌬Rv1813c mutant was significantly delayed to 80 days (P ϭ 0.018) (Fig. 7D) . Two of the BALB/c SCID mice infected with the M. tuberculosis ⌬Rv1813c mutant survived the infection, which was terminated after 115 days (Fig. 7D) . Importantly, no bacteria were detected in the lungs of these survivors (data not shown). In contrast, the time to death for mice infected with the complemented M. tuberculosis ⌬Rv1813c mutant was significantly enhanced to 42 days (P ϭ 0.0035) (Fig. 7D) , consistent with the increased bacterial burdens observed in target organs of infection. Thus, Rv1813c and/or Rv1812c is required for aspects of M. tuberculosis virulence in vivo.
IL-1␤ and IL-12 p40 levels are altered in mice following infection with M. tuberculosis ⌬Rv1813c or complemented mutant derivative. A previous study indicated that Rv1813c encoded , and TB247 (closed squares) were similarly assessed during aerated growth in 7H9 broth. H37Rv, TB79, TB99, and TB108 growth/survival was also assessed during static growth in 7H9 broth (C), following exposure to 0.4% SDS (D), or following exposure to 1 or 10 mM H 2 O 2 (E). Optical density at 600 nm was used to assess growth characteristics (A and B). The CFU/ml (C to E) was determined by removing an aliquot at designated times with serial dilution plating on 7H10 OADC and counting resulting colonies after 3 to 4 weeks of incubation at 37°C. All values represent the means and standard errors of the means from three independent cultures. a secreted antigen that is recognized by the immune system (35) . To determine whether mice infected with the M. tuberculosis ⌬Rv1813c mutant or complemented mutant exhibited altered cytokine levels, lung and spleen homogenates were filter sterilized and analyzed for various cytokines (IL-1␤, IL-2, IL-6, IL-10, IL-12 p40, IL-13, IFN-␥, and TFN-␣) by Bio-Plex. Significant differences in IL-1␤ and IL-12 p40 levels were observed in lung homogenates from the M. tuberculosis ⌬Rv1813c mutant and complemented mutant derivative compared to the wild-type parent (Fig.  8) . Interestingly, variation in IL-6, IL-10, IL-13, IFN-␥, and TNF-␣ was also observed between M. tuberculosis strains in lung homogenates from infected animals 4 weeks postinfection but not at the other time points examined (Fig. 8) . Similar trends in cytokine alterations were observed in spleen homogenates (Fig. 9) . The altered IL-1␤ and IL-12 p40 cytokines also correlated with general differences in the abundance of immune cells and areas of inflammation in the lungs of animals infected with ⌬Rv1813c and complemented mutant compared to the wild-type parent (Fig.  10A to C) . Importantly, the ⌬Rv1813c complemented mutant was observed in regions of the lung where inflammation was observed (Fig. 10D) . Thus, loss of Rv1813c expression alters the proinflammatory immune response to infection.
DISCUSSION
M. tuberculosis utilizes multiple strategies to recognize and respond to environmental stresses. Two TCSSs, MprAB and DosRST, have been implicated in aspects of M. tuberculosis persistence and are thought to sense conditions likely to be encountered within granulomatous lesions. Of note, a subset of genes comprising the regulons of these systems overlap, suggesting that these systems coregulate a core set of determinants important for adaptation within the human host (26, 27, 47) . Here, we describe the initial characterization of the Rv1813c-Rv1812c operon that is directly coregulated by MprA and DosR.
Rv1813c and Rv1812c are upregulated in a DosR-dependent manner in response to hypoxia, nitric oxide, and carbon monoxide (33, 50, 55, 65) . Previous characterization of the Rv1813c promoter region revealed that phosphorylated DosR binds to several elements upstream of this gene (10) . Results presented here carried out with unphosphorylated DosR are in large agreement with the previous description. Interestingly, while unphosphorylated DosR protects a large region upstream of Rv1813c containing the P1, P2, and S binding sites, it fails to protect the E region. While the contribution of each DosR element upstream of Rv1813c has yet to be elucidated, DosR-regulated genes often require multiple binding sites for full transcriptional induction, and cooperative DosR binding at promoter elements is largely phosphorylation and concentration dependent (10, 11, 13, 64) . These observations suggest that in vivo, DosR binding to the E region occurs only under conditions in which DosR concentrations are high.
Previous studies carried out in our laboratory and others have also indicated that Rv1813 expression is regulated by MprA (27, 47) . Specifically, Rv1813c was shown to be downregulated in a mprA::Km r mutant relative to wild-type M. tuberculosis H37Rv, and further investigation revealed that Rv1813c is positively regulated by MprA under multiple stress conditions that activate MprAB signaling (27) . EMSAs carried out as part of this study demonstrate that MprA also directly binds to the Rv1813c promoter region. The region protected by MprA contains two potential MprA recognition motifs. Alignment of these motifs against other known MprA binding sites using MEME indicates that thymines positioned at T 1 , T 3 , T 12 , and T 14 within the predicted consensus are key residues important for MprA binding. EMSAs carried out with a probe in which a subset of these thymines was changed to cytosines supports this contention. Thus, DosR and MprA both recognize sequences in the Rv1813c upstream region and bind to sites that are adjacent to and partially overlapping each other.
Promoter mapping studies using 5= RACE indicate that DosR and MprA regulate Rv1813c expression from the same TSP. This TSP is positioned 218 nucleotides upstream of the Rv1813c translational start site. The position of DosR binding at P1 and P2 relative to the Rv1813c TSP is consistent with the distance of DosR binding upstream of TSPs from other DosR regulon determinants (10) (11) (12) (13) 64) . Interestingly, a putative SigC binding site is also visible near the Ϫ10 and Ϫ35 regions upstream of the Rv1813c TSP (Fig. 3A) . SigC has been implicated in regulation of other DosRdependent genes (11, 12, 23) and may also participate in transcriptional initiation of Rv1813c. The region protected by MprA lies immediately upstream of the observed Rv1813c TSP and overlaps with a portion of the putative SigC binding sequence. While additional TSPs in the Rv1813c upstream region were not observed by 5= RACE, it remains possible that there is an MprA-specific TSP that is expressed but at levels below the detection limit for this assay. Overall, we favor a model whereby MprA and DosR compete for occupation at the Rv1813c promoter, with relative abundance and individual phosphorylation states of each response reg- ulator contributing to their affinities and thus activation of transcription. Given the location of MprA binding, it is possible that when both proteins are present, MprA modulates DosR-dependent activation of Rv1813c. Similarly, binding of DosR to the E region may inhibit transcription from the Rv1813c TSP, allowing for negative feedback inhibition when DosR concentrations are high.
The majority of DosR-regulated genes are clustered in discrete operons, a characteristic that may enhance coordinated expression of these genes (65) . While Rv1813c and Rv1812c are transcribed in the same direction, they are transcribed divergently from erg3 (Rv1814) and in the opposite direction of mgtC (Rv1811). This genomic organization is unique to M. tuberculosis and the closely related M. bovis (see Fig. S1 in the supplemental material). While Rv1813c and Rv1812c are both upregulated under various DosR-activating conditions (33, 50, 65) , the intergenic region between Rv1813c and Rv1812c is unable to mediate expression of a gfp reporter in a DosR-dependent manner, and no apparent DosR consensus sequences are present upstream of Rv1812c (10) . Using primers spanning the Rv1813c-Rv1812c intergenic region, we show that Rv1813c and Rv1812c are carried on a single transcript, indicating that these determinants constitute a bona fide two-gene operon that is expressed from a promoter upstream of Rv1813c. However, Rv1812c can also be expressed independently of Rv1813c, as indicated by the identification of an Rv1812c-specific TSP located Ϫ113 bp from the translation start site of this gene. Microarray analyses suggest that Rv1812c, but not Rv1813c, is within the regulon of two additional TCSSs, SenX3-RegX3 and PhoPR (22, 49) . A putative PhoP binding site (24) is present 130 nucleotides upstream of the Rv1812c translational start site in M. tuberculosis (data not shown). Whether PhoP or any other transcription factor directly regulates expression of Rv1812c from this TSP remains to be determined. Thus, the regulation of Rv1813c and Rv1812c expression is likely complex and warrants further investigation.
Despite extensive investigation into regulation of DosR-and MprA-dependent genes, the function of proteins encoded by many of these determinants remains largely undefined. Rv1813c encodes a hypothetical protein. It has a predicted Tat-dependent signal sequence and may be secreted into the culture filtrate (43) . Interestingly, exposure of immune cells derived from tuberculosis patients to recombinant Rv1813c elicits an IFN-␥ response ex vivo, suggesting that this protein is produced during infection, is secreted by M. tuberculosis, and is recognized by the immune system (35) . Although also uncharacterized, Rv1812c is a predicted type II NADH dehydrogenase and has been identified within the culture filtrate (38) . Deletion of Rv1813c in M. tuberculosis results in a growth advantage of this strain in laboratory medium when cultures are shaken, a phenotype that can be reversed by overexpression of Rv1813c from the heterologous hsp60 promoter. The with hematoxylin and eosin to visualize cells (A to C) and acid-fast stained to visualize Mycobacterium (D) using standard techniques. All lung tissues depicted were taken from mice at week 4 postinfection, and the presence of Mycobacterium was confirmed by CFU determination (Fig. 7) . Acid-fast staining bacilli can be seen within areas of inflammation, with several clusters of bacteria highlighted with arrows (D). Images in panels A to C are at ϫ100 magnification, and the image in panel D is at ϫ1,000 magnification. mechanism underlying this growth advantage in M. tuberculosis ⌬Rv1813c is currently unclear and is the topic of future investigation. Nonetheless, growth/survival differences are not observed following exposure of M. tuberculosis ⌬Rv1813c to cell wall/membrane stress, hypoxia, and oxidative stress or during growth of this strain within macrophages in vitro. Thus, while Rv1813c is upregulated by both DosR and MprA in M. tuberculosis under a variety of conditions, Rv1813c does not appear to be necessary for adaptation to these in vitro stress environments per se.
Despite the lack of stress-induced phenotypes, the ⌬Rv1813c mutant strain is attenuated for organ burden and lethality in the low-dose murine model of tuberculosis. Furthermore, a substantive proinflammatory response, evident by the production of cytokines IL-1␤ and IL-12, is seen in mice infected with the wildtype M. tuberculosis parent but not in the ⌬Rv1813c mutant. Cytokines IL-1␤ and IL-12 have both been implicated in aspects of protective immunity against M. tuberculosis infection (20, 31, 45) . The attenuated immune response to ⌬Rv1813c infection correlates with lower bacterial burdens, reduced lung pathology, and delayed time to death in mice. Collectively, these phenotypes indicate that Rv1813c is important for aspects of M. tuberculosis growth and/or survival in vivo. Additionally, as a predicted secreted protein and identified antigen, Rv1813c may interact directly with and/or modulate the host immune response. Finally, Rv1812c likely also plays a role in M. tuberculosis physiology, virulence, and immune response to infection, as the M. tuberculosis ⌬Rv1813c complemented strain containing two copies of Rv1812c is hypervirulent and stimulates elevated IL-1␤ and IL-12 levels compared to the wild-type parent. The observed alterations in cytokine levels do not appear to be a consequence of differences in bacterial burden between these strains within target organs of infection. Rather, these alterations appear to be due to the loss of Rv1813c in the case of the M. tuberculosis ⌬Rv1813c mutant or increased production of Rv1812c in the M. tuberculosis ⌬Rv1813c mutant complemented with Rv1813c-Rv1812c. Investigation into the function of Rv1813c and Rv1812c and their specific roles in M. tuberculosis physiology and virulence remain topics of further study.
